Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

On India trip, U.S. diplomat cites 'concern' about anti-patent actions

06.03.2014 / Fierce Pharma

One of India&#39;s solutions to get lower-cost meds for its impoverished and uninsured<span style="font-size: 13px;">–compulsory licenses–has ignited drugmakers&#39; ire. And with an Indian committee currently assessing a batch of patented drugs as compulsory licensing candidates, the U.S. is fighting back–politely, at least so far.</span>

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: